STAT January 9, 2020
Matthew Herper, Damian Garde, Rebecca Robbins and Adam Feuerstein

Biotech is celebrating a platinum anniversary next week: 20 years since J.P. Morgan took over the industry’s biggest conference, an annual ritual of brokered mergers, broken promises, and breakthrough science.

The J.P. Morgan Healthcare Conference is more than a venue for deals. It’s a place where fierce arguments break out, where industry memes get made, and where biotech examines its warts and wrinkles.

With that in mind, STAT decided to look back at the record. What emerged was not just a series of recollections about a conference, but the history of an industry, chock-full of lessons about management, leadership, and communication. Over the past two decades, many of the biggest heroes and villains in the pharmaceutical industry have graced the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Digital Health, Technology, Trends
It's Not Just Congress. There's Plenty of State-Level Action on PBMs, Drug Costs and Prices | AMCP 2024
The Blame Game in Healthcare Innovation
Infographic: Top 5 Workforce Issues in Nursing
'Podnosis': Inside Morgan Health's investment strategy and the art of the pitch
Solo? Group? Academia? Pros and cons to these practice settings

Share This Article